TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
NSPR

InspireMD Inc

Healthcare · Medical Devices

0.6225$ +0.5% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Income Statement

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Income Statement NSPR
Line item 2008 2009 2010 2011 2012 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
100.0% – 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0% 100.0%
– – 54.5% 53.3% 51.0% 53.3% 46.8% 72.2% 112.8% 94.6% 78.8% 72.4% 79.7% 96.7% 83.2% 78.4% 70.9% 78.5% 70.5%
– – 45.5% 46.7% 49.0% 46.7% 53.2% 27.8% -12.8% 5.4% 21.2% 27.6% 20.3% 3.3% 16.8% 21.6% 29.1% 21.5% 29.5%
– – 27.1% 74.6% 74.6% 74.6% 85.3% 310.3% 157.7% 68.2% 46.2% 42.6% 79.4% 89.9% 114.7% 151.0% 128.6% 194.5% 167.1%
0.1% – 0.3% 259.5% 374.7% 259.5% 184.1% 323.8% 276.5% 264.0% 187.8% 134.1% 140.3% 246.6% 164.7% 161.6% 179.0% 218.4% 230.6%
0.1% – 0.3% 374.7% – 374.7% 362.5% 868.8% 571.7% 409.2% 319.3% 239.0% 284.1% 421.0% 344.2% 383.5% 369.9% 499.5% 576.5%
-0.1% – -0.3% -328.0% – -328.0% -309.3% -841.0% -627.1% -403.8% -298.2% -211.4% -263.8% -417.7% -327.4% -361.9% -340.7% -478.0% -547.0%
0.1% – 0.3% 23.1% 0.0% 23.1% 279.0% 49.1% 44.8% 42.9% 6.5% 0.0% 1.1% 6.4% 3.5% 0.5% – – –
-0.1% – -68.1% -328.7% – -328.7% -600.2% -890.1% -674.5% -446.7% -304.6% -201.1% -269.2% -424.1% -330.9% -357.0% -319.9% -455.8% -542.6%
0.1% – 0.5% 0.3% 0.3% 0.3% 0.2% 0.4% 0.2% 0.1% 1.0% -10.3% 0.6% 0.2% 1.0% 0.5% 1.0% 0.8% 0.7%
-0.1% – -0.5% -329.0% – -329.0% -600.4% -890.5% -674.7% -446.7% -305.6% -201.1% -269.8% -424.3% -331.9% -357.6% -321.0% -456.6% -543.3%
-0.1% – -64.2% -303.3% – -303.3% -305.0% -831.6% -616.6% -393.7% -291.7% -207.1% -259.6% -411.6% -323.8% -358.2% -316.2% -451.8% -537.3%

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?